DigitalDx Ventures

Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial intelligence for rapid and precise infectious disease discovery. Their software and laboratory technology enable clinicians and researchers to guide patient treatment and improve health outcomes.

At GLX Analytix, we combine a new, proprietary class of blood biomarker with AI to bring personalized medicine to your healthcare. We envision a future where patients are diagnosed earlier, empowered to monitor themselves, and treatment plans are optimized. We aim to improve lives all over the world. GLX Analytix is an Industrial Partner to Harvard Medical / Wyss Diagnostic Accelerator and Winner of Roche Future of Healthcare Award "...this approach has a clear potential to improve the lives of patients all over the world.” - Dr. Tim M. Jaeger, Global Head of Diagnostics Information Solutions, Roche

Optina Diagnostics is a diagnostics company that uses innovative retinal imaging and artificial intelligence to provide non-invasive diagnostic test results for under-diagnosed diseases. Optina Diagnostics identifies patient retinal features that assist physicians in assessing patients' health status and disease risk in order to provide timely and appropriate care. Optina Diagnostics reimagines brain health assessment and provides critical information early in disease progression.

NephroSant is a fast-paced diagnostic startup founded by physicians, with a team of world-class scientists, engineers and clinicians, focused on applying the founding team's years of clinical research expertise to improve global kidney health.

AEENA Dx is developing a saliva-based platform for the detection of cancer and other diseases

Optina Diagnostics is a diagnostics company that uses innovative retinal imaging and artificial intelligence to provide non-invasive diagnostic test results for under-diagnosed diseases. Optina Diagnostics identifies patient retinal features that assist physicians in assessing patients' health status and disease risk in order to provide timely and appropriate care. Optina Diagnostics reimagines brain health assessment and provides critical information early in disease progression.